These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12417840)

  • 1. Ventricular rate control in the elderly: is digoxin enough?
    Falk RH
    Am J Geriatr Cardiol; 2002; 11(6):353-6. PubMed ID: 12417840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
    Koh KK; Song JH; Kwon KS; Park HB; Baik SH; Park YS; In HH; Moon TH; Park GS; Cho SK
    Int J Cardiol; 1995 Nov; 52(2):167-74. PubMed ID: 8749878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evidence regarding the drugs used for ventricular rate control.
    Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
    J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral diltiazem and digoxin alone and in combination in chronic atrial fibrillation.
    Gupta RP; Mittal SR; Gokhroo RK
    J Assoc Physicians India; 1995 Nov; 43(11):781. PubMed ID: 8773040
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
    Botto GL; Bonini W; Broffoni T
    Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
    Farshi R; Kistner D; Sarma JS; Longmate JA; Singh BN
    J Am Coll Cardiol; 1999 Feb; 33(2):304-10. PubMed ID: 9973007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment of atrial fibrillation.
    Herbert ME; Votey SR; Rutz F
    West J Med; 1996 Jan; 164(1):63. PubMed ID: 8779205
    [No Abstract]   [Full Text] [Related]  

  • 11. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.
    Schreck DM; Rivera AR; Tricarico VJ
    Ann Emerg Med; 1997 Jan; 29(1):135-40. PubMed ID: 8998092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should chronic atrial fibrillation be treated with digoxin?].
    Garre K
    Ugeskr Laeger; 1990 Aug; 152(35):2475-8. PubMed ID: 1976285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy.
    Dayer M; Hardman SM
    Am J Geriatr Cardiol; 2002; 11(6):370-5. PubMed ID: 12417843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise.
    Steinberg JS; Katz RJ; Bren GB; Buff LA; Varghese PJ
    J Am Coll Cardiol; 1987 Feb; 9(2):405-11. PubMed ID: 3805530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone.
    Wattanasuwan N; Khan IA; Mehta NJ; Arora P; Singh N; Vasavada BC; Sacchi TJ
    Chest; 2001 Feb; 119(2):502-6. PubMed ID: 11171729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.
    Lewis RV; Laing E; Moreland TA; Service E; McDevitt DG
    Eur Heart J; 1988 Mar; 9(3):279-83. PubMed ID: 3289931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.